SCHEMBL29735166

SCHEMBL29735166

COc1cc(Br)cc2c(CN3C(=O)c4ccccc4C3=O)n[nH]c(=O)c12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 4/20 0.64
▸ WDR77 Q9BQA1 4/20 0.64
▸ RXFP1 Q9HBX9 1/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ GAA P10253 2/20 0.40
▸ AR P10275 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ ALPL P05186 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23087658 1.00 PRMT5 (0.64) PRMT5WDR77RXFP1CYP3A4TSHR
SCHEMBL27002364 0.89 PRMT5 (0.61) PRMT5WDR77RXFP1GAAKMT2A
SCHEMBL29915065 0.89 PRMT5 (0.61) PRMT5WDR77RXFP1GAAKMT2A
SCHEMBL31496831 0.86 PRMT5 (0.60) PRMT5WDR77RXFP1CYP3A4TSHR
SCHEMBL23087513 0.85 PRMT5 (0.67) PRMT5WDR77HSD17B10ARRECQL
SCHEMBL29735135 0.85 PRMT5 (0.67) PRMT5WDR77HSD17B10ARRECQL
SCHEMBL29735278 0.84 PRMT5 (0.69) PRMT5WDR77CYP3A4CYP2C19LMNA
SCHEMBL23087447 0.84 PRMT5 (0.69) PRMT5WDR77CYP3A4CYP2C19LMNA
SCHEMBL31496822 0.83 PRMT5 (0.53) PRMT5WDR77RXFP1CYP3A4TSHR
SCHEMBL30752949 0.83 PRMT5 (0.53) PRMT5WDR77RXFP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304720-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
WO-2022192745-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-09-15 — — WO disclosed
EP-4028388-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-07-20 — — EP disclosed
Send feedback